title: Combination approaches to immunotherapy: the radiotherapy example.
abstract: The marquee cell of the immune response, the T lymphocyte, is exquisitely sensitive to ionizing radiation. Moreover, the majority of cells of the hematopoietic lineage, with their high turnover and radiation sensitivity, are effectively ablated by relatively low radiation doses, such that total-body irradiation is an effective immunosuppressive therapy. Despite and sometimes because of these facts, the immune system may underlie some portion of the therapeutic effects of radiation. In this review, we will discuss these processes, and go on to discuss current therapies combining radiation therapy with immunotherapy for the treatment of cancer.
authors.affiliation: Robert W Franz Cancer Center, Earle A Chiles Research Institute, Providence Portland Medical Center, Portland, OR 97213, USA. michael.gough@providence.org
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Gough
authors.forename: Marka R
authors.initials: MR
authors.lastname: Crittenden
mesh_terms: D000818:Animals; D049109:Cell Proliferation / Q000528:radiation effects; D003131:Combined Modality Therapy; D006706:Homeostasis / Q000528:radiation effects; D006801:Humans; D007167:Immunotherapy; D018836:Inflammation Mediators / Q000378:metabolism; D008213:Lymphocyte Activation / Q000528:radiation effects; D008212:Lymphocyte Depletion / Q000379:methods; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011878:Radiotherapy; D051193:Toll-Like Receptors / Q000378:metabolism
chemical_list: D018836:Inflammation Mediators; D051193:Toll-Like Receptors